Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All vitamin B12 studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin B12Vitamin B12 (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Scientific Opinion on the substantiation of health claims related to vitamin B12 and red blood cell formation (ID 92, 101), cell division (ID 93), energy-yielding metabolism (ID 99, 190) and function of the immune system (ID 107) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA, EFSA Journal, doi:10.2903/j.efsa.2009.1223
Oct 2009  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
34th treatment shown to reduce risk in February 2022
 
*, now with p = 0.023 from 4 studies.
Lower risk for recovery.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,500+ studies for 81 treatments. c19early.org
European Food Safety Administration review concluding that there is a causal relationship between the intake of vitamin B12 and immune system function.
EFSA et al., 1 Oct 2009, peer-reviewed, 18 authors.
This PaperVitamin B12All
Scientific Opinion on the substantiation of health claims related to vitamin B12 and red blood cell formation (ID 92, 101), cell division (ID 93), energy-yielding metabolism (ID 99, 190) and function of the immune system (ID 107) pursuant to Article 13(1)
Jean-Louis Bresson, Albert Flynn, Marina Heinonen, Karin Hulshof, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Hildegard Przyrembel, Seppo Salminen, J J ) Strain, Stephan Strobel, Inge Tetens, Henk Van Den Berg, Hendrik Van Loveren, Hans Verhagen
EFSA Journal, doi:10.2903/j.efsa.2009.1223
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to
INFORMATION AS PROVIDED IN THE CONSOLIDATED LIST The consolidated list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006 3 submitted by Member States contains main entry claims with corresponding conditions of use and literature from similar health claims. The information provided in the consolidated list for the health claims subject to this opinion is tabulated in Appendix C. APPENDICES APPENDIX A BACKGROUND AND TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION The Regulation 1924/2006 on nutrition and health claims made on foods 6 (hereinafter "the Regulation") entered into force on 19 th January 2007. Article 13 of the Regulation foresees that the Commission shall adopt a Community list of permitted health claims other than those referring to the reduction of disease risk and to children's development and health. This Community list shall be adopted through the Regulatory Committee procedure and following consultation of the European Food Safety Authority (EFSA). Health claims are defined as "any claim that states, suggests or implies that a relationship exists between a food category, a food or one of its constituents and health". In accordance with Article 13 (1) health claims other than those referring to the reduction of disease risk and to children's development and health are health claims describing or referring to: a) the role of a nutrient or other substance in growth, development and the functions of the body;..
References
Green, Cobalamins
Stabler, Vitamin B12
Wintergerst, Maggini, Hornig, Contribution of selected vitamins and trace elements to immune function, Ann. Nutr. Metab
{ 'type': 'article-journal', 'language': 'eng', 'container-title': 'EFSA Journal', 'DOI': '10.2903/j.efsa.2009.1223', 'ISSN': '1831-4732', 'issue': '2009; 7(9):1223', 'medium': 'JD', 'publisher': 'EFSA', 'publisher-place': 'IT', 'title': 'Scientific Opinion on the substantiation of health claims related to vitamin B12 and red blood ' 'cell formation (ID 92, 101), cell division (ID 93), energy-yielding metabolism (ID 99, 190) and ' 'function of the immune system (ID 107) pursuant to Article 13(1) of Regulation (EC) No 1924/2006', 'URL': 'https://data.europa.eu/doi/10.2903/j.efsa.2009.1223'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit